Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047342 · ClinicalTrials.gov registry record
Assessing the Impact of myHealth Rewards New Hire Enrollment Emails
A clinical trial of Health Promotion and Wellness Programs, sponsored by Geisinger Clinic.
- Completed
- Registry status
- 824
- Enrollment target
- 1
- Study location
NCT04047342: Completed study of Health Promotion and Wellness Programs, sponsored by Geisinger Clinic.
NCT04047342 is a study of Health Promotion and Wellness Programs that has completed, run by Geisinger Clinic. The registered enrollment target is 824 participants, below the 8,896-participant average among 10 other Health Promotion trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04047342, a study of Health Promotion and Wellness Programs, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- 824 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to evaluate, prospectively, the potential impact, on myHealth Rewards wellness program enrollment prior to the 2019 November submission deadline, of sending different messages via email to Geisinger Health Plan (GHP) members who have just been hired.
Primary Outcome
Enrollment in the myHealth Rewards program (yes/no) within 7 full days of the beginning of the intervention for each cohort (i.e., when the emails are first sent within each weekly new hire cohort). Data will be aggregated across cohorts, including the July 16 cohort and every subsequent cohort through the week prior to reminder emails scheduled to be sent out in October, 2019.
Conditions Studied
Interventions
- BEHAVIORAL Welcome email
- BEHAVIORAL Loss frame
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 824 participants |
| Start Date | 2019-07-16 |
| Est. Completion | 2020-07-01 |
What the finished NCT04047342 record still lists
NCT04047342 is an observational study that tracks outcomes without assigning an intervention. The registered 824 participants enrollment target is mid-sized for trials with a published cap, below the 8,896-participant average among 10 other Health Promotion trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Health Promotion appearing as the primary indexed condition, and to 2 interventions - of which Welcome email is the first listed.
NCT04047342 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04047342 about?
NCT04047342 is a clinical study titled "Assessing the Impact of myHealth Rewards New Hire Enrollment Emails". The purpose of the study is to evaluate, prospectively, the potential impact, on myHealth Rewards wellness program enrollment prior to the 2019 November submission deadline, of sending different messages via email to Geisinger Health Plan (GHP) members who have just been hired.
What is the current status of trial NCT04047342?
This trial is currently completed. The enrollment target is 824 participants. The study started on 2019-07-16. Estimated completion is 2020-07-01.
What conditions does trial NCT04047342 study?
This clinical trial studies the following conditions: Health Promotion, Wellness Programs.
What interventions are being tested in trial NCT04047342?
The interventions under investigation include: Welcome email (BEHAVIORAL), Loss frame (BEHAVIORAL).
Who is sponsoring clinical trial NCT04047342?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04047342 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Health Promotion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04047342's enrollment target sits among peer trials
824 5th of 10 higher than 6 of 10 other Health Promotion trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Health Promotion trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention
RECRUITING · NA
-
Health Impact 360: Advancing Physical, Social, and Mental Health Among Marginalized Communities for Cardiovascular Health Equity
ACTIVE NOT RECRUITING · NA
-
Well-Child Care Clinical Practice Redesign: A Parent Coach-Led Model of Care
COMPLETED · NA
-
Caregiver Stress: Interventions to Promote Health and Wellbeing
COMPLETED · NA
-
Efficacy of Communication Modalities for Promoting Flu Shots
COMPLETED · NA
-
SWITCH Implementation Effectiveness Trial
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06944509 · 824 participants · NA
RADIQAL Study (Radiation Dose and Image Quality Trial)
- NCT05630482 · 825 participants · NA
Randomized Trial of Healthy Family Foundations
- NCT06097728 · 825 participants · Phase 3
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
- NCT07102641 · 825 participants · Phase 4
Post-cesarean Analgesia: Comparing Effectiveness of Staggered v. Simultaneous Therapies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI